Related Experiment Video
Updated: Mar 23, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Disulfiram neuropathy: two case reports
Anh Thu Tran1, Richard A Rison2, Said R Beydoun3
1Neuromuscular Division, Department of Neurology, Keck School of Medicine, University of Southern California, 1520 San Pablo Street Suite 3000, Los Angeles, CA, 90033, USA.
Background:
Neuropathy is a rare adverse side effect of disulfiram therapy and is under-recognized. There have been few case reports documenting this side effect.
Case Presentation:
Two cases of disulfiram peripheral neuropathy are discussed. The first case is that of a 25-year-old Caucasian woman who was exposed to disulfiram therapy for a total of 8 months and developed pain and stiffness that prevented her from walking. The second case is that of a 46-year-old Caucasian woman who developed sudden-onset numbness in her lower extremities with progression to pain. Her symptoms improved over the course of 2 months after cessation of disulfiram therapy. In both cases, symptoms improved after cessation of disulfiram therapy.
Conclusions:
Disulfiram neuropathy occurs in persons with a history of chronic alcohol use. It is under-recognized and often attributed to alcoholic neuropathy given its comorbidity with alcoholic neuropathy. A greater understanding of this side effect may reduce neurologic complications related to disulfiram neuropathy and aid in early withdrawal of this offending agent.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
CNS Depressants: Alcohol and Nicotine
Drug Toxicity: Risk factors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions
